Background illustration for clinical trials search

Paid Clinical Trials Stamford

Discover 1,022 paid clinical trials in Stamford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Lake Success NY, Mineola NY, New York NY, New Haven CT,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Lake Success NY, Mineola NY, New York NY, Farmington CT,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase3, Recruiting

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

for
Metastatic Head-and-neck Squamous-cell Carcinoma,
Location: Lake Success NY, New York NY, New Haven CT,
Sponsor: AVEO Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06064877

Phase3, Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Hyde Park NY, New York NY, New Haven CT,
Sponsor: Debiopharm International SA

Sex: All

Age: 12+

Code: NCT04855656

Phase1, Recruiting

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

for
Relapsed or Refractory Multiple Myeloma
Location: Lake Success NY, Shirley NY, Farmington CT,
Sponsor: Celgene

Sex: All

Age: 18+

Code: NCT05519085

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Lake Success NY, Mineola NY, Paramus NJ, New York NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Mineola NY, New York NY, Shirley NY, Farmington CT,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

for
Endometrial Cancer
Location: Mineola NY, Teaneck NJ, New York NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06952504

Phase3, Recruiting

Study of AVZO-021 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: Mineola NY, New York NY, New Haven CT, Philadelphia PA,
Sponsor: Avenzo Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05867251

Phase1, Phase2, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Mineola NY, New York NY, New Haven CT, Brooklyn NY,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Lake Success NY, The Bronx NY, New York NY,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06545955

Phase3, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: New Hyde Park NY, New York NY, New Haven CT,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

for
Recurrent B-Cell Non-Hodgkin Lymphoma,
Location: Mineola NY, New York NY, New Haven CT, Chicago IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05272384

Phase1, Recruiting

PARTNER 3 Trial - Aortic Valve-in-Valve

for
Aortic Stenosis, Aortic Stenosis, Severe
Location: Mineola NY, New York NY, Newark NJ, Hartford CT,
Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT03003299

Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Mineola NY, Hackensack NJ, New York NY, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase3, Recruiting

A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Mineola NY, New York NY, New Haven CT, Brooklyn NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07258511

Phase3, Recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

for
Endometrial Cancer
Location: Mineola NY, New York NY, New Haven CT, Syracuse NY,
Sponsor: BioNTech SE

Sex: Female

Age: 18+

Code: NCT06340568

Phase3, Recruiting

A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

for
Metastatic Castration-resistant Prostatic Neoplasms
Location: Mineola NY, New York NY, Brooklyn NY, Hartford CT,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07164443

Phase3, Recruiting

A Prospective Sub-Study of the Global Hypophosphatasia Registry

for
Hypophosphatasia
Location: Mineola NY, Hartford CT, Boston MA, Charlottesville VA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 0+

Code: NCT05234567

Recruiting

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

for
Barrett Esophagus, Barretts Esophagus With Dysplasia,
Location: New Hyde Park NY, New York NY, Bristol CT, Danville PA,
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT05530343

Recruiting